2927 — AFC-HD AMS Life Science Co Share Price
Last Trade - 00:00Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 12.13 | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | 2.2% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Aug | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 14,631.26 | 15,141.75 | 15,795.64 | 16,252.89 | 15,819.28 | 18,500 | 19,000 | 1.88% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -12.04 | +47.73 | -9.31 | -10.78 | +1.7 | +73.93 | +2.4 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
AFC-HD AMS Life Science Co Ltd is a Japan-based company mainly engaged in the development of the healthcare business and the pharmaceutical business. The Company is engaged in the research and development, product design, manufacture and sale of health foods and cosmetics, manufacture and sale of Chinese medicine medicines, general medicines, generic medicines, healthcare products, the sale of natural foods, as well as planning of health information programs. The Company operates in two business segments. The Healthcare segment is engaged in the manufacture and sale of health foods and cosmetics, as well as the provision of original equipment manufacturers (OEM). The Pharmaceutical segment is engaged in the manufacture and sale of ethical drugs and over-the-counter drugs, as well as the sale of generic drugs. The Company is also engaged in the management of restaurants through subsidiary.
Directors
- Takehiko Asayama PRE (44)
- Hiroyuki Shiratori CEX (49)
- Kenichi Nishimura SMD (62)
- Shigenori Fukuchi (44)
- Shigeki Tamura (45)
- Masahiro Ikeda OTH (68)
- Naoya Unno (43)
- Katsuhiko Yoshida OTH (55)
- Last Annual
- August 31st, 2020
- Last Interim
- May 31st, 2021
- Incorporated
- December 8th, 1980
- Public Since
- March 3rd, 2005
- No. of Shareholders
- 10,711
- No. of Employees
- 592
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 14,092,687
- Address
- 3-6-36, Toyoda, Suruga-ku, SHIZUOKA-SHI, 422-8027
- Web
- http://www.ams-life.com/
- Phone
- +81 542810585
- Auditors
- Deloitte Touche Tohmatsu LLC
Latest News for 2927
Upcoming events for 2927
Dividend For 2927.T - 15.0000 JPY
Similar to 2927
EUGLENA ORD
Tokyo Stock Exchange
MORISHITA JINTAN ORD
Tokyo Stock Exchange
NIPPI ORD
Tokyo Stock Exchange
FAQ
As of Today at 19:56 UTC, shares in AFC-HD AMS Life Science Co are trading at ¥1,138. This share price information is delayed by 15 minutes.
Shares in AFC-HD AMS Life Science Co last closed at ¥1,138 and the price had moved by +61.88% over the past 365 days. In terms of relative price strength the AFC-HD AMS Life Science Co share price has outperformed the Nikkei 225 Index by +35.84% over the past year.
The overall consensus recommendation for AFC-HD AMS Life Science Co is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
The AFC-HD AMS Life Science Co dividend yield is 1.98% based on the trailing twelve month period.
Last year, AFC-HD AMS Life Science Co paid a total dividend of ¥23, and it currently has a trailing dividend yield of 1.98%.Looking ahead, shares in AFC-HD AMS Life Science Co are due to go ex-dividend on 2021-08-30 and the next dividend pay date is 2021-11-01.
AFC-HD AMS Life Science Co are due to go ex-dividend on 2021-08-30 and the next dividend pay date is 2021-11-01. The historic dividend yield on AFC-HD AMS Life Science Co shares is currently 1.98%.
To buy shares in AFC-HD AMS Life Science Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥1,138, shares in AFC-HD AMS Life Science Co had a market capitalisation of ¥16bn.
Here are the trading details for AFC-HD AMS Life Science Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 2927
Shares are classified based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
AFC-HD AMS Life Science Co does not currently have a style classification.
The analyst consensus target price for shares in AFC-HD AMS Life Science Co is ¥1,350. That is 18.63% above the last closing price of ¥1,138.
Analysts covering AFC-HD AMS Life Science Co currently have a consensus Earnings Per Share (EPS) forecast of ¥92 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like AFC-HD AMS Life Science Co. Over the past six months, its share price has outperformed the Nikkei 225 Index by +25.02%.
As of the last closing price of ¥1,138, shares in AFC-HD AMS Life Science Co were trading +17.02% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The AFC-HD AMS Life Science Co PE ratio based on its reported earnings over the past 12 months is 12.62. The shares last closed at ¥1,138.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
AFC-HD AMS Life Science Co's management team is headed by:
- Takehiko Asayama - PRE
- Hiroyuki Shiratori - CEX
- Kenichi Nishimura - SMD
- Shigenori Fukuchi -
- Shigeki Tamura -
- Masahiro Ikeda - OTH
- Naoya Unno -
- Katsuhiko Yoshida - OTH
We do not have data on AFC-HD AMS Life Science Co's shareholders